SCHEMBL9059536

SCHEMBL9059536

CN/C(N)=N/c1ccccc1C

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 16/20 0.66
▸ GRIN2D O15399 11/20 0.66
▸ GRIN3B O60391 11/20 0.66
▸ GRIN1 Q05586 11/20 0.66
▸ GRIN2A Q12879 11/20 0.66
▸ GRIN2B Q13224 11/20 0.66
▸ GRIN2C Q14957 11/20 0.66
▸ GRIN3A Q8TCU5 11/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ PABPC1 P11940 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ TSHR P16473 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ EBP Q15125 1/20 0.66
▸ TMEM97 Q5BJF2 1/20 0.66
▸ ESR1 P03372 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9059537 1.00 SIGMAR1 (0.66) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29765243 0.86 SIGMAR1 (0.68) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Ditolylguanidine SCHEMBL29364709 0.79 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Ditolylguanidine SCHEMBL80339 0.79 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Ditolylguanidine SCHEMBL158674 0.79 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9227594 0.79 SIGMAR1 (0.70) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL29812626 0.79 SIGMAR1 (0.60) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Ditolylguanidine SCHEMBL3388414 0.79 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1931049 0.79 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7435471 0.79 SIGMAR1 (0.58) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 — — WO disclosed
Send feedback